PDS Biotechnology PDSB
NASDAQ PDSB
$0.75 +0.01 (+1.35%)
At close: Sep 30, 2026 · 4:00 PM EDT

PDS Biotechnology (PDSB) Capital Expenditures (2014 - 2024)

Updated

PDS Biotechnology (PDSB) recorded Capital Expenditures of $29,000 in FY2024.

Analysis

PDS Biotechnology (PDSB) Capital Expenditures (2014 - 2024) Analysis & Trends

Starting with FY2013, PDS Biotechnology's Capital Expenditures history includes 6 years.

  • The FY2024 figure is the highest annual Capital Expenditures in data going back to FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 PDS Biotechnology 41.94 Mn 41.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.00
Dec 31, 2017 27,970.00
Sep 30, 2017 55,089.00
Jun 30, 2017 16,378.00
Mar 31, 2017 89,284.00
Dec 31, 2016 347,295.00
Sep 30, 2016 144,093.00
Jun 30, 2016 118,030.00
Mar 31, 2016 77,287.00
Dec 31, 2015 505,662.00
Sep 30, 2015 352,254.00
Jun 30, 2015 361,092.00
Mar 31, 2015 86,078.00
Dec 31, 2014 619,643.00
API Access

PDS Biotechnology Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PDSB&period=max&api_key=YOUR_API_KEY